• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:11年的人口统计学、临床及预后特征

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: 11-year Demographic Clinical and Prognostic Characteristics.

作者信息

Acar Ayda, Yoldas Ayse H, Turk Bengu G, Karaarslan Isil, Sagduyu Ilgen E, Ceylan Can, Unal Idil, Ozturk Gunseli

机构信息

Department of Dermatology and Venereology, Ege University Medical Faculty, Izmir, Turkey.

出版信息

Indian J Dermatol. 2022 Jan-Feb;67(1):12-18. doi: 10.4103/ijd.IJD_671_21.

DOI:10.4103/ijd.IJD_671_21
PMID:35656249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9154133/
Abstract

BACKGROUND

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute, life-threatening, severe drug reactions. Randomized studies on these diseases are difficult to perform.

AIMS AND OBJECTIVES

The purpose of this study was to summarize the demographic and clinical characteristics of patients with SJS and TEN in a tertiary hospital in Turkey.

MATERIALS AND METHODS

We evaluated the records of 33 patients with SJS and TEN who were followed in our clinic or examined between January 2008 and June 2019, retrospectively. Age, sex, time of admission to hospital, causative drug, presence of concomitant disease, skin findings, mucosal involvement, the severity-of-illness score for TEN, the medication used, antibiotic use, transfer to intensive care, development of complications, and death or discharge status were noted.

RESULTS

Of the 33 patients, 11 (33.3%) had SJS, 3 (9.1%) had SJS/TEN overlap, and 19 (57.6%) had TEN. The majority (60.6%) of the patients were female. Nineteen (57.6%) patients had one, and 13 (39.4%) had more than one suspected drug exposure in their history. The most commonly suspected drugs were antibiotics. Twelve (36.4%) patients had intensive care unit hospitalization. Ten (30.3%) patients died.

CONCLUSION

The demographic data of our study were consistent with the literature. Similar to the literature, antibiotics were the most common reaction-causing drugs. However, antiepileptic drugs, which were more frequently reported in other studies, were identified as suspicious in only one patient. We believe that our study will contribute to the determination of characteristics of this rare disease with real-life data.

摘要

背景

史蒂文斯 - 约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)是急性、危及生命的严重药物不良反应。针对这些疾病进行随机研究很困难。

目的

本研究的目的是总结土耳其一家三级医院中SJS和TEN患者的人口统计学和临床特征。

材料与方法

我们回顾性评估了2008年1月至2019年6月期间在我们诊所就诊或接受检查的33例SJS和TEN患者的记录。记录了患者的年龄、性别、入院时间、致病药物、合并疾病情况、皮肤表现、黏膜受累情况、TEN疾病严重程度评分、使用的药物、抗生素使用情况、转入重症监护病房情况、并发症发生情况以及死亡或出院状态。

结果

33例患者中,11例(33.3%)患有SJS,3例(9.1%)患有SJS/TEN重叠综合征,19例(57.6%)患有TEN。大多数患者(60.6%)为女性。19例(57.6%)患者有过一种,13例(39.4%)患者有过一种以上可疑药物暴露史。最常怀疑的药物是抗生素。12例(36.4%)患者入住了重症监护病房。10例(30.3%)患者死亡。

结论

我们研究的人口统计学数据与文献一致。与文献相似,抗生素是最常见的引起反应的药物。然而,在其他研究中更频繁报道的抗癫痫药物,在我们的研究中仅在1例患者中被确定为可疑。我们相信我们的研究将有助于用实际生活数据确定这种罕见疾病的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/c5363bced7f4/IJD-67-12-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/53deb9535bbd/IJD-67-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/9113cd8de92d/IJD-67-12-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/c5363bced7f4/IJD-67-12-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/53deb9535bbd/IJD-67-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/9113cd8de92d/IJD-67-12-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2a/9154133/c5363bced7f4/IJD-67-12-g003.jpg

相似文献

1
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: 11-year Demographic Clinical and Prognostic Characteristics.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:11年的人口统计学、临床及预后特征
Indian J Dermatol. 2022 Jan-Feb;67(1):12-18. doi: 10.4103/ijd.IJD_671_21.
2
Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.儿童中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症重叠,重点关注新型抗癫痫药物:单中心 25 年回顾性研究。
Pediatr Dermatol. 2021 Jul;38(4):812-818. doi: 10.1111/pde.14598. Epub 2021 May 31.
3
Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.儿童药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:一家三级医院 20 年的研究。
World J Pediatr. 2017 Jun;13(3):255-260. doi: 10.1007/s12519-016-0057-3. Epub 2016 Sep 20.
4
Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.儿童史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)及SJS-TEN重叠综合征的致病药物与临床结局
Indian J Dermatol. 2012 May;57(3):199-200. doi: 10.4103/0019-5154.96192.
5
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.新加坡一家综合医院中 Stevens-Johnson 综合征和中毒性表皮坏死松解症的特征和模式:治疗结果。
Acta Derm Venereol. 2012 Jan;92(1):62-6. doi: 10.2340/00015555-1169.
6
Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.药物性史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)及SJS-TEN重叠综合征:一项多中心回顾性研究
J Postgrad Med. 2011 Apr-Jun;57(2):115-9. doi: 10.4103/0022-3859.81865.
7
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.对来自中国的213例史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
8
Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:对1980年至2020年PubMed/MEDLINE病例报告的系统评价
Front Med (Lausanne). 2022 Aug 24;9:949520. doi: 10.3389/fmed.2022.949520. eCollection 2022.
9
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床特征及治疗结果
Exp Ther Med. 2015 Aug;10(2):519-524. doi: 10.3892/etm.2015.2549. Epub 2015 Jun 5.
10
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Fresh Look at an Old Foe.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:重新审视一个老对手。
Indian J Dermatol. 2023 Jan-Feb;68(1):34-40. doi: 10.4103/ijd.ijd_726_22.

引用本文的文献

1
The Prevalence of Stevens-Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis.抗癫痫药物使用导致史蒂文斯-约翰逊综合征并发症的患病率:一项系统评价和荟萃分析。
Int J Prev Med. 2025 Jul 30;16:41. doi: 10.4103/ijpvm.ijpvm_132_24. eCollection 2025.
2
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 15-year Regional Burn Center Experience.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:一家地区烧伤中心15年的经验。
JPRAS Open. 2025 Feb 8;44:83-92. doi: 10.1016/j.jpra.2025.02.003. eCollection 2025 Jun.
3
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports.

本文引用的文献

1
Stevens-Johnson syndrome and toxic epidermal necrolysis - retrospective review of cases in a high complexity hospital in Brazil.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症 - 巴西一家高复杂度医院的病例回顾性研究。
Int J Dermatol. 2020 Feb;59(2):191-196. doi: 10.1111/ijd.14544. Epub 2019 Jun 7.
2
Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:回顾性描述性研究。
Int J Dermatol. 2019 Nov;58(11):1293-1299. doi: 10.1111/ijd.14493. Epub 2019 Jun 5.
3
Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database.
史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:俄罗斯自发报告数据库分析
Pharmaceuticals (Basel). 2024 May 24;17(6):675. doi: 10.3390/ph17060675.
4
RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.红细胞分布宽度标准差(RDW-SD)和降钙素原(PCT)是史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者院内死亡的潜在预后因素。
Allergy Asthma Immunol Res. 2023 Nov;15(6):812-824. doi: 10.4168/aair.2023.15.6.812.
5
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.评估史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中需改进致敏药物鉴别的必要性。
JAMA Dermatol. 2023 Aug 1;159(8):830-836. doi: 10.1001/jamadermatol.2023.1693.
早期全身皮质类固醇治疗与 Stevens-Johnson 综合征或中毒性表皮坏死松解症患者死亡率的关联:使用全国索赔数据库的回顾性队列研究。
Am J Clin Dermatol. 2019 Aug;20(4):579-592. doi: 10.1007/s40257-019-00443-9.
4
Toxic Epidermal Necrolysis Therapy with TPE and IVIG-10 Years of Experience of the Burns Treatment Center.采用治疗性血浆置换和静脉注射免疫球蛋白治疗中毒性表皮坏死松解症——烧伤治疗中心10年经验
J Burn Care Res. 2019 Aug 14;40(5):652-657. doi: 10.1093/jbcr/irz073.
5
Twelve years of Lyell's Syndrome in the burn unit of São João Hospital Centre.圣若昂医院中心烧伤科12年的莱尔综合征情况
Ann Burns Fire Disasters. 2018 Dec 31;31(4):259-265.
6
A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.一项针对 2006 年至 2016 年新南威尔士州转诊医院中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征管理的 10 年回顾性队列研究。
Int J Dermatol. 2019 Oct;58(10):1141-1147. doi: 10.1111/ijd.14426. Epub 2019 Mar 25.
7
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.Stevens-Johnson 综合征/中毒性表皮坏死松解症患者住院死亡率风险预测模型的建立与验证-ABCD-10
JAMA Dermatol. 2019 Apr 1;155(4):448-454. doi: 10.1001/jamadermatol.2018.5605.
8
British Association of Dermatologists' guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018.英国皮肤科医师协会《2018年儿童和青少年史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症管理指南》
Br J Dermatol. 2019 Jul;181(1):37-54. doi: 10.1111/bjd.17841. Epub 2019 Apr 25.
9
Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective review of 10-year experience.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:10 年回顾性研究。
Int J Dermatol. 2019 Sep;58(9):1069-1077. doi: 10.1111/ijd.14409. Epub 2019 Mar 1.
10
Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.多学科团队治疗中毒性表皮坏死松解症。文献综述与治疗结果
Burns. 2018 Jun;44(4):807-815. doi: 10.1016/j.burns.2017.10.022. Epub 2018 Apr 4.